Jerry J. Baack, the Chief Executive Officer of Bridgewater Bancshares Inc, has sold a total of 40,000 shares of the bank's common stock in two recent transactions. This move, reported in a filing with the SEC, highlights Baack's management of his personal investment portfolio while continuing to lead the company.
The sale of shares took place on November 2 and November 3, 2026, at prices of approximately $20.25 to $20.70 per share. Following these transactions, Baack retains ownership of 1,137,769 shares of the bank. Such actions by a CEO can often signal confidence or concerns about the company's future, and may influence investor sentiment.
Background
Bridgewater Bancshares Inc operates in the state commercial banking sector. The company is incorporated in Minnesota and is listed under the SEC file number 001-38412. The bank's fiscal year ends on December 31. The recent filings indicate Baack's active engagement in managing his stock holdings within the company.
What the Filing Says
The SEC filing, dated November 4, 2026, indicates that Baack sold 20,000 shares on November 2 and another 20,000 shares on November 3. The filing specifies that the reported prices were weighted averages, with the shares sold in multiple transactions. Baack stated, "These shares were sold in multiple transactions at prices ranging from $20.12 to $20.40, inclusive." He also committed to providing detailed information about the sale upon request.
Impact
This decision may affect investor perceptions of Bridgewater Bancshares, particularly in the context of the state commercial banking industry. As Baack is both a director and an officer of the company, his actions are closely watched by shareholders and analysts alike. The sale could be interpreted in various ways, potentially influencing market reactions and investor confidence.
What's Next
The filing does not say what happens next.
Read Next
Delaware Group Tax Free Fund files N-CSR with updates
Voyageur Mutual Funds Files N-CSR Report for Q3 2026
Voyageur Mutual Funds Reports Financial Results in N-CSR Filing
Fowler Todd C. Files Form 3 as Director of Saia Inc.
Matt Robbins Reports Significant Stock Transactions at Atmos Energy
CFO Hans van Houte of Nurix Therapeutics sells shares









